Cargando…
Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial
OBJECTIVES: Gonadotropin-releasing hormone (GnRH) and pituitary gonadotropins, which appear to be proinflammatory, undergo profound secretory changes during events associated with rheumatoid arthritis (RA) onset, flares, or improvement e.g. menopausal transition, postpartum, or pregnancy. Potential...
Autores principales: | Kåss, Anita, Hollan, Ivana, Fagerland, Morten Wang, Gulseth, Hans Christian, Torjesen, Peter Abusdal, Førre, Øystein Torleiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603957/ https://www.ncbi.nlm.nih.gov/pubmed/26460564 http://dx.doi.org/10.1371/journal.pone.0139439 |
Ejemplares similares
-
Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study
por: Kåss, AS, et al.
Publicado: (2014) -
Editorial: Gonadotropin-Releasing Hormone Receptor Signaling and Functions
por: Bjelobaba, Ivana, et al.
Publicado: (2018) -
Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018) -
Development of the gonadotropin‐releasing hormone system
por: Duittoz, Anne H., et al.
Publicado: (2022) -
Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment
por: Taktaz, T., et al.
Publicado: (2015)